InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Dearen Danny L., Executive. Officer active across 3 companies, notably Axonics, Inc.. Cumulatively, 20 reports have been recorded. Breakdown: 0 buy · 4 sells. Total volume traded: €1.5m. Activity tracked since 20 May 2021. The latest transaction was disclosed on 21 May 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Dearen Danny L.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations20 total
16,965 shares0Common StockSEC:0001756438-26-000003:0
44,030 shares0Common StockSEC:0001493152-26-002664:0
3,997 shares0Common StockSEC:0001756438-26-000002:0
11,247 shares0Common StockSEC:0001415889-25-008535:0
36,919 shares0Common StockSEC:0001562180-23-007189:0
11,250 shares0Common StockSEC:0001562180-23-007190:0
7,699 shares@ US$49.43559.7% of flowCommon StockSEC:0001562180-23-004641:0
13,208 shares@ US$14.194.7% of flowCommon StockSEC:0001562180-23-003685:0
10,363 shares@ US$59.930815.5% of flowCommon StockSEC:0001562180-23-003685:1
9,637 shares@ US$60.503714.6% of flowCommon StockSEC:0001562180-23-003685:2
2,001 shares@ US$14.190.7% of flowCommon StockSEC:0001562180-23-003669:0
6,633 shares@ US$14.192.4% of flowCommon StockSEC:0001562180-23-003425:0
5,000 shares0Common StockSEC:0001562180-23-000874:0
656 shares@ US$75.601.4% of flowCommon StockSEC:0001562180-22-006685:0
1,616 shares@ US$1.320.1% of flowCommon StockSEC:0001562180-22-006102:0
12,329 shares@ US$25.8215.2% of flowCommon StockSEC:0001562180-22-002348:0
6,421 shares@ US$25.825.0% of flowCommon StockSEC:0001562180-22-002063:0
20,000 shares@ US$14.198.6% of flowCommon StockSEC:0001562180-22-001105:0
10,805 shares@ US$14.194.6% of flowCommon StockSEC:0001562180-22-000563:0
28,291 shares@ US$14.1911.2% of flowCommon StockSEC:0001562180-21-003716:0
20 of 20 declarations
About Dearen Danny L.
Dearen Danny L. is an executive linked to Axonics, Inc., where he is President & CFO, and a director of Beta Bionics, Inc. and InspireMD, Inc. He has 20 filings in total, and within the recent filings covered here, sell transactions amount to EUR 1502148, with activity ranging from 2021-05-24 to 2026-05-26, and the most common transaction nature being option exercise.
